Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Marksans Pharma Logo
Marksans Pharma Growth Score
79
CB Rank
519547
Heat Score
55
Marksans Pharma is a pharmaceutical company that actively deals in R&D and offers CRAMS to healthcare companies.
Founded
obfuscation
PublicPost-IPO Equity Mumbai, Maharashtra, India1001-5000 marksanspharma.com/
Health Care
Medical
Pharmaceutical
Overview

Marksans Pharma
Total Funding
obfuscation
Growth Score
79
Heat Score
55

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score79
-10 pts
in past quarter
Heat Score 55
12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Marksans Pharma

CB Rank
519547
Marksans Pharma is a pharmaceutical company that actively deals in R&D and offers CRAMS to healthcare companies.
Founded
obfuscation
PublicPost-IPO Equity Mumbai, Maharashtra, India1001-5000 marksanspharma.com/
Health Care
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Marksans Pharma Ltd
Operating Status Active
Stock Symbol  NSE:MARKSANS
Company Type For Profit
Founders  Mark Saldanha
About the Company
Marksans Pharma develops R&D capabilities including dossier development, chemical synthesis, process optimization, formulation development, analytical development, and conducting stability studies.
Phone Number +1 22 4001-20-00
Contact Email info@marksanspharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
Marksans Pharma is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Finished Dosage Pharmaceutical Formulations
Manufacture and marketing of finished dosage pharmaceutical formulations for various therapeutic segments.
Health & Wellness Consumer Self-Care Products
Over-the-counter consumer products for pain management, upper respiratory, digestive health, vitamins, minerals, supplements, and skin care.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
2
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
SpringHill Management Logo
SpringHill Management
—
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
—
SpringHill Management Logo
SpringHill Management
—
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
—
SpringHill Management Logo
SpringHill Management
—
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
—
SpringHill Management Logo
SpringHill Management
—
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
—
SpringHill Management Logo
SpringHill Management
—
Post-IPO Equity - Marksans Pharma Logo
Post-IPO Equity - Marksans Pharma
—

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Employee Profiles 3 Contacts 39

Employee Profiles

News

News and Press

News•Apr 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

7,978
507.62%
 in past month

Active Website Tech Count

3Marksans Pharma is actively using 3 technologies for its website, according to BuiltWith. These include Euro and  CommonCrawl Top 5m.

Total IP

1Marksans Pharma has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Marksans Pharma's headquarters? Marksans Pharma is located in Mumbai, Maharashtra, India.Who invested in Marksans Pharma? Marksans Pharma has 2 investors including SpringHill Management and  UTI Ventures.When was the last funding round for Marksans Pharma? Marksans Pharma closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Marksans Pharma's competitors? Alternatives and possible competitors to Marksans Pharma may include THINQ Pharma-CRO, Rx Biotech, and  Coral Laboratories.How much funding has Marksans Pharma raised to date? Marksans Pharma has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|